But patients and advocates are pushing back against this neglect, and a new documentary called “Unrest” shines a light on their struggle. The film follows Jennifer Brea, a patient with ME/CFS, as she fights for recognition and research funding for the disease. The documentary has sparked a movement, with patients using social media to share their stories and raise awareness.
Advocates are calling for more research funding and better medical education to improve the diagnosis and treatment of ME/CFS. They are also pushing for the FDA to approve new therapies for the disease, which affects an estimated 2.5 million Americans.
One of the key challenges in treating ME/CFS is the lack of understanding of the disease among healthcare providers. Many patients report feeling dismissed or stigmatized by doctors who do not believe their symptoms are real. This lack of recognition can lead to delays in diagnosis and appropriate treatment.
Advocates are working to change this by educating healthcare providers about the symptoms and impact of ME/CFS. They are also calling for more research into the biological mechanisms of the disease, which could lead to new treatment options.
Overall, the ME/CFS community is coming together to demand better care and support for patients. Through advocacy, education, and research, they hope to improve the lives of those living with this debilitating disease.
For more information on ME/CFS and how you can get involved in advocacy efforts, visit the #NotJustFatigue website or watch the documentary “Unrest” for a firsthand look at the challenges faced by patients with this condition.
ME/CFS groups like Ansell’s are pushing back against the Trump administration’s decision to cut funding for ME/CFS research at Columbia University. This move has left the ME/CFS community reeling, as it eliminated one of the few remaining research centers dedicated to studying the condition.
In response to these funding cuts, advocacy groups have taken action. They have penned a letter to Kennedy to express their concerns, met with congressional offices to discuss the impact of the cuts, and recently released a report outlining the economic consequences of ME/CFS. The report, based on a survey of one hundred individuals with confirmed ME/CFS diagnoses, revealed some alarming statistics.
According to the report:
– 94% of respondents experienced a decrease in income due to their illness, with 42% earning less than half of what they made before falling ill.
– 22% of patients surveyed were forced to permanently leave the workforce, and more than half had to reduce their working hours due to the debilitating symptoms of ME/CFS.
– 30% of individuals relied on disability benefits as their primary source of income.
– Shockingly, 16% of respondents were denied disability benefits, and 37% of those who applied reported feeling dismissed or not taken seriously by evaluators.
These findings underscore the harsh reality faced by individuals living with ME/CFS and highlight the urgent need for continued research and support for this overlooked and often misunderstood condition.
In the face of these challenges, the ME/CFS community remains steadfast in their fight for recognition, funding, and support. By raising awareness, advocating for policy changes, and sharing their stories, they hope to bring about positive change for those affected by this debilitating illness.
As we continue to follow the developments in the ME/CFS community, it is clear that the fight is far from over. With determination and perseverance, Ansell’s and other advocacy groups are working tirelessly to ensure that the voices of individuals with ME/CFS are heard and that their needs are met.
